Cholera—Modern Pandemic Disease of Ancient Lineage by Morris, J. Glenn
Cholera has affected humans for at least a millennium 
and persists as a major cause of illness and death worldwide, 
with recent epidemics in Zimbabwe (2008–2009) and Haiti 
(2010). Clinically, evidence exists of increasing severity of 
disease linked with emergence of atypical Vibrio cholerae 
organisms that have incorporated genetic material from 
classical biotype strains into an El Tor biotype background. 
A key element in transmission may be a recently recognized 
hyperinfectious phase, which persists for hours after passage 
in diarrheal feces. We propose a model of transmission in 
which environmental triggers (such as temperature) lead 
to increases in V. cholerae in environmental reservoirs, 
with spillover into human populations. However, once the 
microorganism is introduced into a human population, 
transmission occurs primary by “fast” transmission from 
person to person (taking advantage of the hyperinfectious 
state), without returning to the aquatic environment.
C
holera has been an unwanted companion among human 
civilizations for at least a millennium, with suggestions 
that it has existed in India “since immemorial times” (1). 
Its impact in Bengal society was sufﬁ  cient to have resulted 
in recognition of a goddess of cholera, Oladevi (or Oola 
Beebee), who required propitiation to protect villages 
from the disease (2). Global pandemic spread of cholera 
from its ancestral home in Bengal was ﬁ  rst documented in 
1817 (1), the beginning of what has been designated as the 
ﬁ  rst pandemic. In the intervening 2 centuries, cholera has 
continued to ebb and ﬂ  ow from southern Asia to other parts 
of the known world, with 6 additional pandemics identiﬁ  ed. 
During the third pandemic, which ravaged London in 
1854, John Snow conducted his pioneering epidemiologic 
studies (and gained fame for removal of a pump handle). 
We are currently in the throes of the seventh pandemic 
(caused by V. cholerae of the El Tor biotype), which 
originated almost 50 years ago in the Celebes. In contrast 
to the earlier 6 pandemics, at no time in these past 50 years 
has cholera retreated to its southern Asian home. It has 
instead established endemicity at multiple sites around the 
globe and continues to trigger major localized epidemics, 
including the epidemics in Zimbabwe during 2008–2009 
(3) and Haiti during 2010.
In 2009, the most recent year for which data are 
available, 221,226 cholera cases were reported to the 
World Health Organization (WHO) from 45 countries 
(4). This number includes 4,946 deaths, for a case-fatality 
rate of 2.24%. Although the disease was reported from all 
continents, 98% of cases reported during 2009 were from 
Africa, driven in part by large numbers from the latter 
part of the 2008–2009 Zimbabwe epidemic. However, 
these numbers should be interpreted with caution because 
of well-recognized problems with underreporting in the 
WHO system, particularly because cholera is no longer 
a notiﬁ  able disease and countries can choose whether to 
report cases. In 2 examples, no cholera cases were included 
in the annual WHO cholera summary report for 2009 (4) 
from India or Bangladesh, despite anecdotal evidence to 
the contrary.
Cholera today takes advantage of breakdowns in 
sanitation and health infrastructure, often in the setting 
of natural and complex disasters. More notably, cholera 
has survived the transition from ancient to modern world, 
with the establishment of endemic foci in virtually every 
continent. We have learned a great deal about cholera during 
the past few decades. Major advances have been made in 
therapy, which has decreased expected case-fatality rates 
to <0.5%. However, we are just coming to appreciate the 
evolutionary capabilities of the microorganism and the 
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complexity of transmission pathways, an understanding of 
which is essential to ultimate control of the disease.
Clinical Features and Management
Clinically, cholera is a simple disease. Its 
manifestations result almost entirely from action of cholera 
toxin, a protein enterotoxin excreted by the bacterial cell. 
The A subunit of cholera toxin activates adenylate cyclase, 
causing increased Cl– secretion by intestinal crypt cells 
and decreased NaCl-coupled absorption by villus cells and 
resulting in a net movement of electrolytes (and water) 
into the lumen of the intestine (5). All manifestations of 
the disease can be reproduced by administration of cholera 
toxin: in studies conducted in the 1970s at the University 
of Maryland (Baltimore, MD, USA), volunteers given 25 
μg of pure cholera toxin had >20 L of rice-water feces; 
ingestion of as little as 5 μg of puriﬁ  ed toxin resulted in 
1–6 L of diarrhea in 5 of 6 volunteers (6).
Severity of illness varies widely. In the most severe 
form of the disease, cholera gravis, patients can pass >1 L 
of diarrheal feces per hour. Feces are passed effortlessly, 
with the diarrhea assuming a rice-water appearance. If 
volumes are not repleted, this diarrhea can result, in as 
little as 6–8 hours, in circulatory collapse, shock, and 
death. Shock, even if adequately treated, may precipitate 
acute renal failure. Severe acidosis results from fecal loss 
of bicarbonate, exacerbated by hypotension-related lactic 
acidosis and renal failure.
Although cholera gravis is a devastating disease, 
studies in the early 1970s suggested that such severe cases 
accounted for only 11% of total infections among persons 
infected with strains of the classical biotype (responsible 
for the sixth cholera pandemic); 59% of infections were 
asymptomatic or inapparent, and the remainder represented 
illness of mild to moderate severity. In studies during that 
same period, only 2% infected with seventh pandemic 
biotype El Tor strains had severe disease, and 75% of 
infected persons were asymptomatic (7). Although the El 
Tor biotype has persisted, its relative lack of virulence has 
not; recent studies have noted substantial increases in the 
percentage of patients with severe dehydration (8), and 
the percentage of asymptomatic infected patients appears 
to be much smaller (<50%, in a recent study by Harris et 
al. [9]). As described below, these observations coincide 
with the appearance of new atypical V. cholerae strains that 
include classical biotype genetic material within an El Tor 
background (10,11).
The cornerstone of therapy is replacement of lost ﬂ  uid. 
With an infrastructure able to provide adequate rehydration 
therapy, case-fatality rates should be <1%, ideally <0.5%. 
In mild to moderate cases, rehydration can generally be 
successfully accomplished with oral rehydration solution. 
In patients who are severely dehydrated (loss of 10% of 
body weight) intravenous rehydration is almost always 
necessary; limited anecdotal reports suggest that use of 
intravenous therapy is becoming more frequent in areas 
where cholera is endemic and epidemic, consistent with 
concerns about increasing severity of illness. In early 
placebo-controlled studies, tetracycline reduced duration 
of diarrhea, total volume of diarrhea, and days of excretion 
of V. cholerae by >50%; more recent studies demonstrated 
equivalent or better results with ciproﬂ  oxacin  and 
azithromycin. However, antimicrobial drug use is also 
clearly associated with development of resistance, leading 
to current WHO recommendations that antimicrobial 
agents be limited to use in patients with severe dehydration. 
As recently suggested by Nelson et al. (12), extending use 
of antimicrobial drugs to a larger patient group may be 
reasonable, particularly in light of increasing awareness 
of direct transmission of the microorganism from person 
to person, as discussed below. Zinc supplementation also 
has been recognized as a potentially useful adjunct to 
therapy; recent studies among children in Bangladesh have 
shown that its administration resulted in a 12% reduction in 
duration of diarrhea and 11% reduction in fecal volume in 
patients compared with controls (13).
Genetics/Microbiology
V. cholerae is a diverse species and a natural (and 
common) inhabitant of estuarine environments around the 
world. Distribution depends on water temperature (optimal 
growth at water temperatures >20°C) and salinity (14). In 
contrast to most other Vibrio species, it is able to grow in 
fresh water and is often present in inland rivers and lakes 
in regions where it is endemic. In areas with seasonal 
variations in water temperatures, the microorganism shows 
clear seasonality: environmental counts increase during 
warmer periods and decline (or become nondetectable) 
during cold weather. In studies in Peru (15), V. cholerae 
counts in the Rimac River (at a site above Lima where 
sewage contamination was minimal) spiked ≈2 months 
after an initial summer rise in water temperature but then 
returned to a nondetectable level within 1–2 months (online 
Technical Appendix, wwwnc.cdc.gov/EID/pdfs/11-1109-
Techapp.pdf). The reason for the sharp drop in counts 
after the initial spike (a pattern also seen in some ponds 
in Bangladesh [16]) is not clear. One hypothesis is 
that it is related to rapid increases in the number of V. 
cholerae–speciﬁ  c lytic bacteriophages in the local aquatic 
environment (17,18), providing natural predation as a 
countermeasure to the initial rapid increase in numbers of 
the microorganism.
V. cholerae can assume a variety of survival forms, 
including a shift to what has been termed a viable but 
nonculturable form, which is often associated with bioﬁ  lms. 
Strains can also assume a rugose phenotype (identiﬁ  able 
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on culture by a characteristic rough/wrinkled appearance), 
in which the microorganism produces large quantities of 
an amorphous exopolysaccharide, leading to formation of 
a bioﬁ  lm that is resistant to chlorine, UV light, and other 
standard disinfectants (19). V. cholerae has been closely 
linked with copepods (binding to chitin through the action 
of a speciﬁ  c chitinase) and with zooplankton (14). It has 
also been found in association with chironomid egg masses 
and water hyacinth and can be carried by gulls, other birds, 
and mammals.
Although  V. cholerae as a species is ubiquitous 
in the environment, strains responsible for the disease 
cholera are restricted to a fairly tight subset of strains, as 
reﬂ  ected in clustering seen by multilocus sequence typing 
and sequence analysis. The key gene clusters responsible 
for the manifestations of cholera are associated with 
production of cholera toxin located within the ctx element 
(which is part of a ﬁ  liamentous phage capable of movement 
among strains [20]) and the vibrio pathogenicity island, 
which includes the TCP (toxin-coregulated pilus) gene, 
essential for binding of the microorganism to the intestinal 
mucosa. Other genes common to strains with an epidemic 
phenotype also have been identiﬁ  ed; however, the role of 
many of these genes in the pathogenesis of cholera remains 
to be determined (21,22). Even though virtually all strains 
that cause cholera produce cholera toxin and have the vibrio 
pathogenicity island, not all V. cholerae that carry 1 or both 
of these gene complexes cause cholera; several studies 
have noted the isolation of 1 or both from environmental 
strains that appear to lack other components of the genetic 
background essential for virulence in humans and epidemic 
spread (22,23).
The V. cholerae genome readily undergoes change, 
with extensive genetic recombination through lateral gene 
transfer, resulting in what have been termed shifts and drifts 
in the genome sequence (21). This genetic plasticity is 
reﬂ  ected in the observation that feces from a single infected 
patient in an area where cholera is endemic almost always 
show evidence of infection with multiple genetically 
distinct V. cholerae strains, as deﬁ  ned by variable-number 
tandem-repeat analysis (24). Variability also can be seen in 
serotype. Traditionally, epidemic disease was thought to be 
conﬁ  ned to cholera toxin-producing strains in V. cholerae 
O group 1. However, in 1992, a new serotype, O139, was 
recognized as the cause of a major cholera epidemic on 
the Indian subcontinent (25); emergence was linked to 
replacement of the O group 1 biosynthesis cassette with 
a biosynthesis cassette for the O139 antigen (which also 
encoded material for formation of a capsule). O group 1 
strains continue to predominate among epidemic isolates, 
but serotype clearly does not directly predict virulence; 
cholera-like illness (albeit without epidemic spread) is now 
associated with several different serotypes in addition to 
O1 and O139. These serotypes include O141 and O75 in 
the United States and O37, O10, O12, O6, and O14 in other 
parts of the world (23,26). Changes in serotype, in turn, 
appear to result from lateral transfer of the gene cassettes 
responsible for O-antigen biosynthesis (23,26).
Recent changes or recombinational events also have 
been seen in the ctx gene cluster, with introduction of the 
classical biotype ctx gene into an El Tor background and the 
appearance of strains containing multiple recombinational 
events that have modiﬁ  cations  in  ctx as well as other 
changes that result in loss of traditional El Tor biotype 
characteristics (10,11,27). Although nomenclature remains 
in ﬂ  ux (11), these new atypical strains have, at this point, 
entirely supplanted traditional seventh pandemic El Tor 
strains at a global level (including, most recently, the strain 
responsible for the Haiti epidemic [28]). As discussed 
above, these strains also appear to have major increases 
in virulence (potentially because of increased levels of 
cholera toxin production [29]), comparable with (or in 
excess of) clinical characteristics of the sixth pandemic 
classical biotype strains.
V. cholerae strains associated with epidemic disease 
can respond to changes in their immediate environment 
as they move from environmental reservoirs to humans 
and back. Of particular relevance, it has been shown 
that  V. cholerae passed in human rice-water feces are 
in a “hyperinfectious” state (17,30); in animal studies, 
infectious dose is 1–2 orders of magnitude lower than that 
for strains grown by using traditional in vitro methods. The 
hyperinfectious state lasts at least 5 hours after passage of 
the microorganism from patients. The physiologic basis 
for this effect is unclear but appears to be associated, at 
least in part, with changes that include down-regulation 
of chemotaxis genes (31). V. cholerae as it is passed from 
the body also up-regulates a series of genes that are not 
required for infection but are needed for survival in the 
environment. Twenty-four hours after the microorganism 
reaches the aquatic environment, these shifts, potentially 
combined with lytic phage, result in a dramatic decrease in 
the ability of V. cholerae to cause infection (18).
Epidemiology/Transmission
During the 1960s, the scientiﬁ  c consensus was that 
cholera was transmitted from person to person; a great 
deal of attention was given to the role of convalescent and 
chronic carriage in transmission. During the following 
decades, attention shifted sharply from human carriage 
to environmental reservoirs, with a focus on the role 
of environmental factors in persistence of the disease 
and triggering of epidemics. However, with the advent 
of increasingly sensitive molecular techniques—and 
mathematical modeling approaches—there has been 
movement back toward a transmission model that 
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recognizes the role of environmental reservoirs and direct 
(human-to-human) transmission. In this context, we 
propose the transmission model shown in the Figure.
The aquatic environmental reservoir is critical to 
long-term maintenance of epidemic V. cholerae. These 
reservoirs constitute complex biological systems, with 
modulation of V. cholerae populations by environmental 
conditions (the local microenvironment [15,16] as well as 
global macroenvironmental factors, such as the El Niño/
Southern Oscillation [32]); by predatory bacteriophage 
populations (18); and by ﬂ   uctuations in populations of 
copepods and zooplankton (which can, in turn, be driven 
by predation by ﬁ  sh), binding to chironomid egg masses, 
water hyacinth, carriage by birds and mammals, and a host 
of other variables. At the same time, our data from Lima 
(online Technical Appendix) and from Bangladesh show a 
signiﬁ  cant association between a spike in numbers of ctx-
positive V. cholerae in the environment and subsequent 
occurrence of cholera in the community (15,16), consistent 
with the concept of spillover of the microorganism from the 
environment to human populations.
On the basis of our studies in Lima and Bangladesh, 
peak environmental counts of ctx-positive V. cholerae from 
pristine areas range from 101 to 102 CFU/mL (15,16). The 
infectious dose for V. cholerae (classical biotype) ingested 
by healthy North American volunteers is in the range of 108 
to 1011 CFU/mL, which drops to 104–108 when the inoculum 
is given with bicarbonate or food (5,33). Assuming 
consumption of a large enough volume of contaminated 
material; mixing with food (with the potential for further 
growth in food before consumption (34,35]); and possible 
underlying host factors, such as mild hypochlorhydria 
(which can be associated with Helicobacter pylori infection, 
endemic to many developing countries) and malnutrition, 
transmission from environmental sources that are not 
heavily fecally contaminated becomes plausible. However, 
this infectious dose still would be at the low end of the 
curve, and the percentage of exposed persons becoming 
infected at these low levels is likely to be relatively small.
The picture changes once the microorganism is 
introduced into human populations. Rice-water feces 
contain 107–109  V. cholerae microorganisms per mL. 
Immediately after passage, these microorganisms are in 
a hyperinfectious state (further dropping the infectious 
dose by 1 or 2 logs), generating the opportunity for “fast” 
transmission of V. cholerae to other persons either by 
direct contact with feces or direct contamination of food 
or water within the immediate household environment. 
Microorganisms from feces can also reenter environmental 
reservoirs by fecal contamination. However, one then has to 
deal with dilutional effects within the environment and the 
striking drop in infectivity (noted above) that can occur as 
the microorganism adjusts to an environmental habitat (18). 
In our studies in Lima at the peak of a cholera epidemic, 
we found environmental counts of toxigenic V. cholerae of 
≈105/mL in areas with heavy sewage contamination, so the 
potential for infection from environmental sources clearly 
increases in settings of poor sanitation during epidemics. 
Nonetheless, looking at the relative counts from different 
sources of exposure, these observations are consistent 
with the hypothesis that a major transmission pathway 
for  V. cholerae during an epidemic (particularly at the 
beginning of an epidemic) is through a “fast” pathway, 
taking advantage of the short-lived hyperinfectious state to 
move from person to person, without an intervening “slow” 
transmission step through the environment.
Data from a variety of sources support this hypothesis. 
In studies in Bangladesh that used variable-number 
tandem-repeat analysis (36), we found minimal overlap 
between clinical strain populations circulating in human 
populations and the ctx-positive V. cholerae strains that 
were circulating concurrently in environmental reservoirs. 
If the environmental reservoir was playing a major role 
in the ongoing epidemic, one would have expected to 
see the same genetic types appearing in strains from the 
environment and strains from patients. In mathematical 
models, inclusion of a fast (presumed person-to-person or 
person-to–household environment–to-person) transmission 
pathway that incorporates the short-lived hyperinfectious 
state results in a much better match with outbreak data 
than models that rely solely on a “slow” human-to–aquatic 
environment–to-human pathway (37). In subsequent work 
we have applied our models to data from the 2008–2009 
Zimbabwe epidemic (3). When calculated by province, the 
reproductive number (R0) for the epidemic ranged from 
1.1 to 2.7; our calculations suggest that 47%–94% of this 
value, dependent on province, was accounted for by fast 
(hyperinfectious/presumed person-to-person) transmission.
These observations underscore the need to focus 
prevention efforts on the short window of time after 
passage of feces when strains are in a hyperinfectious state. 
This observation translates into the need for an emphasis on 
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households (and, in particular, an emphasis on households 
with index cases), where exposure to recently excreted 
microorganisms is most likely. This ﬁ  nding ﬁ  ts with those 
from earlier epidemiologic studies from Bangladesh, where 
risk for illness was linked with the presence of an infected 
person in the household, not with whether the household 
used clean tube well water versus potentially contaminated 
surface water for drinking (38). It is also in agreement with 
work by Deb et al. in Kolkata, India, which highlighted 
the inﬂ  uence of household transmission during epidemic 
periods and the associated need to focus on minimizing 
risk for contamination of water and food sources within the 
household (39).
Summary
V. cholerae is a wily opponent. It can live indeﬁ  nitely 
in aquatic reservoirs, making eradication difﬁ  cult,  if 
not impossible; readily undergoes genetic modiﬁ  cation, 
permitting response to changing environmental (and 
human) conditions; and shifts patterns of gene expression as 
it moves from one local environment to another (including 
a shift to a hyperinfectious state immediately after passage 
in feces). Several mathematical models (including models 
developed by the Emerging Pathogens Institute, University 
of Florida [Gainesville, FL, USA] [3]) support the potential 
value of vaccines for disease control and have outlined 
potential strategies for their utilization (40). Although the 
environment remains a critical component of transmission, 
interventions focused increasingly on the household and on 
blocking transmission immediately after passage of feces 
are acutely needed. Ultimately, good sanitation (as part of 
a strong public health infrastructure) is the key to disease 
control. However, until sanitation is widespread (and the 
impact of natural and human-made disasters is minimized), 
ways in which this age-old pathogen causes disease—and 
ways in which it can be controlled—need to continue to be 
explored.
Dr Morris is professor and director of the Emerging 
Pathogens Institute at University of Florida and serves as an 
associate editor of Emerging Infectious Diseases. His research 
interests include cholera in Haiti and in the Indian subcontinent.
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From the Greek cholē for bile. Although the term cholera is now used only to refer to disease caused by the bac-
terium Vibrio cholerae, until the late 19th century any diarrheal illness might be referred to as cholera. For many 
centuries, medicine in Europe was based on Galen’s theory of the 4 humors in the body: blood, bile, black bile, and 
phlegm. Diarrhea and vomiting were interpreted as the body’s attempt to restore balance and good health by expel-
ling excess choler, hence, many gastroenterological illnesses were referred to as cholera. A 12th century treatise, 
the Regimen Sanitatis Salernitanum, described the eff  ects of excess choler thusly, “Your tongue will seem all rough, 
and oft  entimes cause vomits, unaccustomed and hateful, great thirst, your excrements are full of slime, the stomach 
squeamish, sustenance ungrateful, your appetite will seem in nought delighting.” 
Sources:  Dorland’s illustrated medical dictionary. 31st ed. Philadelphia: Saunders; 2007; The Four Temperaments [cited 2011 
Aug 19]. http://www.ﬁ  sheaters.com/fourtemperaments.html; Howard-Jones N. Choleranomalies: the unhistory of medicine as 
exempliﬁ  ed by cholera. Perspect Biol Med. 1972;15:422–33; Oxford dictionaries online. 2011 [cited 2011 Aug 19].  
http://oxforddictionaries.com/deﬁ  nition/cholera?region=us; Tauxe RV. Cholera. In: Hussler WJ, Sussman M, editors. Topley & 
Wilson’s microbiology and microbial infections, 9th ed. Vol. 3: Bacterial infections. New York: Oxford University Press; 1998. p. 
495–512.
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